Target intelligence / Profile preview

Novel transcript, antisense to Ryanodine receptor 3

Molecular classification
Other, non-coding RNA, antisense transcript
01

Overview

This entry represents a **novel, uncharacterized non-coding RNA transcript that is antisense to the Ryanodine receptor 3 (RYR3) gene**[1]. Antisense transcripts can regulate expression of their sense counterparts at the transcriptional or post-transcriptional level, but no specific functions, pathways, disease associations, or drug interactions have been described for this transcript in current literature. It is a genomic annotation from the Ensembl database, detected by high-throughput sequencing, with unknown functional significance and no evidence supporting its designation as a receptor, enzyme, transporter, or other classic drug target. Its primary alias is its Ensembl identifier, ENSG00000276702[1].\n\n**Note:** If you intended to target the protein-coding RYR3 gene (Ryanodine receptor 3), that is a well-characterized ion channel with described disease associations (e.g., muscle disease, neurodegenerative disorders)[3][5]. This entry, however, refers strictly to the antisense non-coding RNA, not the protein-coding receptor. If you need information about the RYR3 protein itself, please specify.

Other names
ENSG00000276702

Beyond the preview

Go deeper on Novel transcript, antisense to Ryanodine receptor 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to Ryanodine receptor 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call